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INSIGHTS FROM MODEL SYSTEMS
Learning from the Slime Mold: Dictyostelium and Human Disease
Charles L. Saxe
Department of Cell Biology, Emory University School of Medicine, Atlanta
When readers of this Journal think about Dictyoste-
lium—rarely, if at all, I suspect—they may conjure up
dim memories either of college laboratory demonstra-
tions involving cell aggregation and cAMP or of watch-
ing the cells develop into tiny fruiting bodies made of
spores and stalks. Yeasts and several invertebrate or ver-
tebrate model systems are widely known for their con-
tributions to our understanding of human disease, but
Dictyostelium is seldom included in this list. Quietly,
over the last few years, however, research on this social
amoeba has revealed some common cellular character-
istics shared across diverse phyla. I wish to suggest that,
despite the wide evolutionary distance that separates hu-
mans and the cellular slime molds, mutations in Dic-
tyostelium discoideum can provide direct insight into
human disease processes. Here, I focus in detail on the
relationship between the Wiskott-Aldrich syndrome
(WAS) and a new family of proteins, the SCARs (sup-
pressor of cAMP receptor defects), identified first in Dic-
tyostelium and subsequently in humans. This class of
proteins appears to be of fundamental significance to the
control of actin cytoskeleton dynamics, which is per-
turbed in WAS and other human genetic diseases.
Experimental Virtues of Dictyostelium
Dictyostelium offers numerous advantages as an ex-
perimental organism. Like other microbial genetic or-
ganisms, Dictyostelium is cultured easily and cheaply
and can be frozen and stored indefinitely. Its genome is
small (∼34 Mb) and, where vertebrates may express a
large number of similar genes with overlapping func-
tions, Dictyostelium often carries only a single orthol-
ogous gene. In addition, expressed sequence tag and ge-
nomic sequencing projects are now well under way.
Most importantly, for ease of genetic manipulation,Dic-
tyostelium may be surpassed only by the yeasts, and
yeast cells differ from both human and Dictyostelium
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cells in important respects—notably as regards motility.
DNA-mediated transformation and homologous recom-
bination make creating knockout and knock-in organ-
isms relatively straightforward. Because multiple select-
able markers are available, strains can be constructed
with complex genotypes. The organism is haploid
throughout its life cycle, so loss-of-function mutations
usually cause phenotypes without the need for further
manipulation. For the same reason, neither recombi-
nation nor complementation is possible by the usual
means (mating) in this system, but mutants may be res-
cued by introducing the gene of interest directly, in either
wild-type or mutant form, and with variable levels of
expression.
Dictyostelium researchers now have available two
means to identify second site suppressors and so to dis-
sect genetic interactions. One recently described method
involves the overexpression of cDNAs from a Dictyos-
telium (Robinson and Spudich 1998). As with the plas-
mid-rescue method in yeast, this approach permits the
screening of libraries for unlinked genes that comple-
ment a specific defect. The other (and older) method is
restriction enzyme–mediated integration (REMI; see
sidebar). This insertional mutagenesis approach typically
yields null alleles in interacting genes. Hence, when
REMI is used to identify a second site suppressor gene,
the suppressor may be predicted to serve as a negative
regulator of the original gene of interest. Unmasking
negative regulatory pathways is often difficult in other
model genetic systems, but REMI makes it relatively easy
in Dictyostelium. These two mutagenesis approaches
would be expected to yield a different set of interacting
genes, and both are well suited to facilitate the cloning
of these genes.
Signaling and Motility in Dictyostelium
Dictyostelium is a free-living amoeba that grows and
divides in the soil. When the food supply, usually bac-
teria, is exhausted, individual cells stop growing and
collect together into a multicellular organism made up
of as many as 105 cells. Complex signal transduction
networks are activated at the beginning of this process
and are used, throughout the remainder of development,
to coordinate the morphogenetic and cellular differen-
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REMI-ing Out the Dictyostelium Genome
Restriction enzyme-mediated integration (REMI) is perhaps the
most valuable tool in the Dictyostelium geneticist’s kit. An in-
sertional mutagenesis technique first described by Schiestl and
Petes (1991) in yeast, REMI involves introducing, into Dic-
tyostelium cells, linearized plasmid DNA along with limiting
amounts of a restriction enzyme that will generate ends com-
patible with those of the plasmid. The restriction enzyme clips
the genomic DNA at one or more sites, permitting the plasmid
to integrate into and disrupt genes more or less at random.
Cells in the resulting mutagenized population will usually carry
only a single genetic lesion, and they can then be screened for
a specific phenotype. Identification of the gene disrupted is gen-
erally straightforward because the plasmid itself marks the re-
gion of interest. Because of the ease of culturing Dictyostelium
cells and the efficiency of DNA-mediated transformation, it is
possible to start a mutagenesis screen with 1109 cells, recover
1104 tranformants, and end up with 10–50 mutants of interest.
Saturation mutagenesis is at least conceivable.
The figure shows the use of molecular genetic techniques to
generate first the cAR2 null strain and then the suppressor strain
that identified SCAR. The left panel shows fruiting bodies that
mark the terminal stage of wild-type Dictyostelium develop-
ment. A cAR2-null strain was produced by targeted gene dis-
ruption, and, as seen in the middle panel, development is ar-
rested at an earlier stage. The cAR2 strain was then subjected
to REMI mutagenesis, and strains able to complete develop-
ment were isolated. The cAR2/SCAR strain shown in the
right panel resulted from that screen. The identification of
SCAR, which encodes an actin-binding protein, as a suppressor
of the motility defects in the cAR background provides im-
portant clues about the regulation of cytoskeletal remodeling
in Dictyostelium cells and in our own.
tiation events that result in the terminal structure, the
fruiting body. Over the years, significant effort has gone
into understanding the signaling mechanisms involved
in regulating Dictyostelium growth and development.
Signaling in Dictyostelium involves the use of extra-
cellular cues to coordinate changes in cell behavior, cell
fate, and cell-cell communication. For example, in veg-
etative, growing cells, extracellular folate stimulates a
chemotactic response, which is thought to be used to
hunt bacteria. This response is GTP-sensitive and is
thought to be mediated through heterotrimeric G protein
signaling (Parent and Devreotes 1996). Another series
of G protein–mediated signals, initiated with cAMP as
the extracellular cue, is used, during the aggregation pro-
cess, to collect individual cells into the multicellular or-
ganism. Study of vegetative growth and early develop-
mental signaling events has led to the identification of
serpentine-type, G protein–coupled receptors, heterotri-
meric and low–molecular weight G proteins, and effec-
tors such as adenylyl cyclase, protein kinase A, and
cAMP-dependent phosphodiesterases (reviewed in
Parent and Devreotes 1996; Soderbom and Loomis
1998). Molecular genetic studies of these signaling path-
ways have also led to the identification of a number of
other well-known signaling components, including MAP
kinases, phosphatidylinositol-3 kinases, phospholipase
C, protein kinase B, and STAT proteins (Drayer and Van
Haastert 1992; Zhou et al. 1995; Aubry et al. 1997;
Kawata et al. 1997; Meili et al. 1999). It appears that
pathways familiar to mammalian cell biologists are con-
served in Dictyostelium.
In addition to fruitful studies in the realm of signaling,
Dictyostelium has proved to be a major contributor to
our understanding of amoeboid cell movement. That
Dictyostelium cells and leukocytes share certain char-
acteristics (Devreotes and Zigmond 1988) has been ap-
preciated for many years. Both use G protein–mediated
signaling to regulate chemotaxis. The second messenger
pathways activated seem to be similar between the two
types of cells, and Rho family GTPases are important
for controlling chemotactic responses.
Closely related to the questions of cell motility is the
study of cytoskeletal reorganization. Dictyostelium cells
have long been a favorite of researchers interested in the
changing interactions of actin filaments and actin-as-
sociated proteins during cell movement and cytokinesis.
The ability to generate null mutants in cytoskeletal pro-
tein genes in this system by means of homologous re-
combination has allowed cell biologists to evaluate the
roles of myosin proteins and other actin-binding proteins
(ABPs) in actin dynamics (Noegel and Luna 1995). For
example, the Dictyostelium “gelation factor,” ABP-120,
is related to a class of human actin–cross-linking pro-
teins, the filamins. A point mutant in ABP-120 results
in a very mild phenotype, but a targeted ablation of this
gene disrupts actin filament networks, blocks pseudopod
formation, and impairs cell motility dramatically. Inter-
estingly, mutations in a human ABP-120 relative, Fi-
lamin-1 (also known as “ABP-280”), lead to periven-
tricular heterotopia, a developmental abnormality in
which cortical neurons fail to migrate (see Fox and
Walsh 1999 [in this issue]).
The possibility that this migration defect and the mo-
tility defects seen in the ABP-120 mutants are similar
may make Dictyostelium a powerful system for studying
the molecular basis of this disease. Because it is feasible
to construct strains with mutations in genes for multiple
ABPs, it is possible to uncover morphogenetic or motility
phenotypes that might otherwise be obscured by func-
tional redundancy among gene products. Thus, although
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Figure 1 Structure of SCAR and its human homologues. Two human relatives of Dictyostelium SCAR, WASp, and N-WASp and the
yeast protein verprolin are all known to interact with actin, as does human SCAR. The conserved domains are indicated, labeled as in Bear et
al. 1998.
the ABP-120–deficient cells are abnormal in chemotaxis
and cell movement, they can complete development, and
mutants lacking another actin–cross-linking protein, a-
actinin, have an even milder phenotype. The double mu-
tant, however, is unable to complete development, and
the synthetic phenotype suggests that the two proteins
have nonoverlapping roles in coordinating actin net-
works.
Motility Defects in Human and Dictyostelium Cells
Signal transduction meets the actin cytoskeleton
whenever cell motility is regulated, as in lamellipodial
or filopodial extension by leukocytes, the development
of microvilli on the surface of epithelial and immune
cells, and the elaboration of neuronal processes.
One specific place where signaling and the actin cy-
toskeleton converge is revealed in patients with WAS.
Patients with this rare X-linked disease typically have
immune deficiencies, thrombocytopenia, and eczema,
and, without an allogenic bone marrow transplant, they
often die at an early age (reviewed in Brickell et al. 1998).
This disorder is clinically quite variable, and some mu-
tations in WASP lead not to full blown WAS but to a
milder condition, X-linked thrombocytopenia (XLT).
Platelets in patients with WAS are unusually small, and
the thrombocytopenia is believed to be primarily due to
increased platelet destruction. The autoimmune defect is
believed to be, at least in part, associated with abnor-
mally shaped T cells. These cells show a dramatic re-
duction in the number of actin-containing microvilli and
a lack of actin filament assembly under the plasma
membrane. Macrophages and monocytes also show ab-
normal cell motility and chemotaxis. All of this points
toward WAS being a defect in some aspect of actin or-
ganization. The gene responsible for WAS was position-
ally cloned in 1994 (Derry et al.), and the product of
this gene, WASP, was subsequently identified as a bind-
ing partner for the Rho family GTPase, CDC42 (As-
penstrom et al. 1996; Kolluri et al. 1996; Symons et al.
1996). More recently, WASP has been shown to bind
both actin and the actin-nucleating protein complex,
arp2/3 (Machesky and Insall 1998); the WASP-related
protein, N-WASP, has been shown to facilitate the for-
mation of actin filaments by coordinating the action of
CDC42 and arp2/3 (Rohatgi et al. 1999).
How do Dictyostelium and SCAR fit into this picture?
We identified the gene for SCAR last year in a second
site suppressor screen involving one of theDictyostelium
cAMP receptors, cAR2 (Bear et al. 1998). Cells lacking
cAR2 progress through the early hours of Dictyostelium
development but then arrest about halfway through the
process (Saxe III et al. 1993). Using REMI (see sidebar),
we isolated strains of cells that bypassed the develop-
mental block and completed development in the absence
of cAR2. One of these strains identified the SCAR gene.
SCAR-null cells are unusually small (∼25% the size
of normal cells) and misshapen in suspension culture.
They have reduced amounts of F-actin, particularly at
the leading edge (Bear et al. 1998), and show striking
defects in cell movement and chemotaxis (J. R. Steiner
and C. L. Saxe, unpublished data). In several respects,
the SCAR cells seem similar to hemopoietic cells in
WAS patients. The connection becomes more apparent
when the SCAR protein is analyzed.
Structure of SCAR, WASP, and Their Homologues
Examination of the SCAR protein revealed a connec-
tion to WASP (fig. 1; Bi and Zigmond 1999). Both pro-
teins have a central polyproline-containing region fitting
the consensus of X(P)4–9 (where , A, L, M, or S).X  G
This type of repeat is present in actin-associated proteins
and is thought to be important for interactions like those
between actin and profilin (Purich and Southwick 1997).
The regions C-terminal to the polyprolines most clearly
connect SCAR with the WASP family of proteins. This
region contains a so-called WASP homology 2 (WH2)
or verprolin domain shown to be necessary for binding
to monomeric actin (Machesky and Insall 1998). Fol-
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Figure 2 A model of SCAR and WASP function in actin polymerization. In this model, receptor-mediated events stimulate GTP exchange
on Rho family GTPases. This signaling may be initiated through cytokines or growth factors binding receptor tyrosine kinases, or possibly
through chemoattractants that act on serpentine receptors. As a result of this signal, WASP and SCAR become activated or localized in a specific
region of the submembranous cytoplasm, presumably close to the activating receptor. SCAR and WASP may also be regulated through the
polyproline-rich region by interactions with profilin and/or SH3-containing proteins such as Nck. Once activated, SCAR and WASP recruit or
activate the arp2/3 complex, which binds to the pointed end of actin and nucleates new actin filaments in this cytoplasmic region. Monomeric
actin and arp2/3 bind to distinct but adjacent regions of SCAR/WASP (the verprolin/WH2 region and acidic regions, respectively), which may
facilitate their interaction. Ultimately, the assembly of these actin filaments drives the formation of filopodia or lamellipodia at the leading edge
of motile cells.
lowing the verprolin/WH2 domain is a region related to
the actin-depolymerizing protein cofilin. Finally, at their
C termini, SCAR and WASP share an acidic domain
containing a single tryptophan residue (Bi and Zigmond
1999). As discussed below, this region was recently
shown to be critical for binding SCAR, WASP, and the
WASP-related protein, N-WASP, to the arp2/3 complex
and for facilitating the polymerization of actin filaments.
One region that distinguishes SCAR from WASP is the
N terminus. In WASP, this region contains a CDC42/
rac-binding domain (GBD/CRIB) and a region that binds
the membrane phospholipid PIP2. No GBD is apparent
in SCAR, but preliminary data suggest that SCAR does
bind the Dictyostelium racC protein (D. J. Seastone, J.
A. Cardelli, W. R. Mahler, and C. L. Saxe, unpublished
data). The N terminus also defines SCAR as a member
of a family of proteins present in organisms as diverse
as Drosophila, Caenorhabditis elegans, mice, and hu-
mans (Bear et al. 1998; Miki et al. 1998). Shortly after
we identified the SCAR family, Machesky and Insall
(1998) reported the protein we called “hSCAR1” as a
binding partner for the p21 component of the arp2/3
complex. WASP was also found to bind p21. arp2/3 is
a complex of seven proteins, comprising the actin-related
proteins arp2 and arp3, as well as p41, p34, p21, p20,
and p16 (Machesky et al. 1997; Welch et al. 1997). This
complex binds to the pointed end of actin and nucleates
barbed end growth and branching of new filaments.
The identification of WASP and a human homolog of
SCAR as binding partners for the arp2/3 complex led
Machesky and Insall (1998) to propose the currently
accepted model of SCAR and WASP function. The model
(fig. 2) predicts that the C-terminal domains of SCAR/
WASP family proteins bind actin and arp2/3 and are
required for the activation of the actin-nucleation func-
tion of the arp2/3 complex. This in turn leads to the
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assembly of actin filaments either at the leading edge of
cells or in filopodia-like structures (Machesky et al.
1999; Rohatgi et al. 1999). In vitro experiments have
shown that SCAR, WASP, and N-WASP directly bind to
actin via the WH2 region and to arp2/3 via the acidic
domain (Machesky and Insall 1998; Rohatgi et al.
1999). SCAR and N-WASP have also been shown, in
vitro, to enhance the ability of arp2/3 to stimulate actin
polymerization (Machesky et al. 1999; Rohatgi et al.
1999).
Modeling WAS in Dictyostelium
On the basis of the molecular model shown in figure
2, one may begin to explain the anomalies associated
with actin assembly in WAS patients. WASP is appar-
ently needed to properly activate arp2/3 and to stimulate
new actin-network formation. The absence of functional
WASP may explain the lack of normal microvilli for-
mation on T cells, the abnormal shape of platelets, and
the motility defects in macrophages and monocytes.
Without WASP, filopodia (structures dependent on
CDC42 activity) and lamellipodia formation (stimulated
by rac1) may be deranged. The fact that different WAS
alleles show different severities of disease is consistent
with different regions playing unique roles in WASP
function.
Structure/function studies in Dictyostelium may play
an important role in fleshing out the details of this
model. There appears to be a single gene for SCAR in
the Dictyostelium genome, as well as a bona fide WASP
gene (Bear et al. 1998). In humans, there are at least
three different SCARs and two WASPs. Use of genetics
to understand the role(s) of individual players will be
much easier in Dictyostelium because of this more lim-
ited redundancy. Introduction of site-directed, random,
or chimeric mutants of SCAR or WASP into a null ge-
netic background will be simple in Dictyostelium. Sev-
eral of the most severe disease alleles found in WAS
individuals occur in the C-terminal region of WASP, in
sequences that are conserved between WASP and SCAR.
These mutations can be introduced into the cloned Dic-
tyostelium genes and expressed in SCAR strains. The
ability to rescue some parts of the SCAR phenotype but
not others could help in our understanding of the dif-
ferent severities of the disease among WAS and XLT
families. Recreation of different mutations and use of
the Dictyostelium mutant phenotype as the readout
should provide much information about the functional
importance of parts of WASP and SCAR. Once the Dic-
tyostelium WASP gene is knocked out, this strategy can
be expanded to include studies in that null background.
There may also be differences between the SCAR and
WASP nulls, which would reveal unique functions for
these homologous proteins. Most likely, human WASP
and SCAR genes can be expressed successfully in Dic-
tyostelium and studied directly in this system (author’s
unpublished data). Dictyostelium-suppressor genetics
may also reveal new levels of regulation of this devel-
opmental pathway. Starting with a SCAR- or WASP-
null strain, the phenotype can be suppressed (partially
or completely) by overexpression or REMI rescue. The
genes identified in such experiments should expand our
understanding of the pathways involved in regulating
SCAR/WASP and may provide the connections from the
cell surface to the actin cytoskeleton.
Although the outlines of SCAR/WASP function are
now becoming clear, there is still a great deal about the
mechanisms of their action that is unknown. How do
the small GTPases regulate SCAR/WASP? Are there
other proteins that interact with them? Do SCAR and/
or WASP function as dimers? How critical is localization
for their function and how is it determined? How is this
coupled to receptor-mediated signaling? Dictyostelium
may not be the only organism in which all of these ques-
tions can be answered, but use ofDictyostelium genetics,
the relative simplicity of the system, and its wealth of
information regarding signaling and actin cytoskeletal
organization may reveal many parts of the puzzle. The
time is ripe to exploit the power of this system to answer
fundamental questions about how cells use extracellular
cues to make differential decisions. WAS may be among
the first human diseases to be elucidated in this system,
but it is unlikely to be the last.
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